749
Participants
Start Date
July 31, 2009
Primary Completion Date
July 31, 2010
Study Completion Date
January 31, 2011
Highly purified menotrophin
"The gonadotrophin starting dose was 150 IU daily for the first 5 days. From stimulation day 6 and onwards, dosing could be adjusted according to individual participant response. The dose adjustment could be by 75 IU per adjustment and could not be done more frequently than every 4 days. The maximum allowed gonadotrophin dose was 375 IU daily and participants could be treated with gonadotrophin for a maximum of 20 days.~NOTE: The gonadotrophins (highly purified menotrophin and the active comparator recombinant FSH) were administered in an identical fashion."
Recombinant FSH
"The gonadotrophin starting dose was 150 IU daily for the first 5 days. From stimulation day 6 and onwards, dosing could be adjusted according to individual participant response. The dose adjustment could be by 75 IU per adjustment and could not be done more frequently than every 4 days. The maximum allowed gonadotrophin dose was 375 IU daily and participants could be treated with gonadotrophin for a maximum of 20 days.~NOTE: The gonadotrophins (highly purified menotrophin and the active comparator recombinant FSH) were administered in an identical fashion."
ERASME Hospital, Anderlecht
UZ Brussel, Brussels
UZ Antwerpen, Edegem
UZ Gent, Ghent
IVF Institute, Pilsen
ISCARE IVF a.s., Prague
Pronatal, Prague
H:S Rigshospitalet, Copenhagen
Amtssygehuset Herlev, Herlev
Sygehus Vestsjælland, Holbæk
H:S Hvidovre Hospital, Hvidovre
KRIOBANK, Bialystok
nOvum, Warsaw
IU Dexeus, Barcelona
GINEFIV, Madrid, Madrid
IVI Madrid, Madrid
Ginemed, Seville
IVI Sevilla, Seville
IVI Valencia, Valencia
Fertilitetscentrum AB Gothenburg, Gothenburg
IVF-kliniken CURA, Malmo
RMC, Malmö, Malmo
Hacettepe University, Ankara
American Hospital, Istanbul
Memorial Hospital, Istanbul
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY